PeriRx
- Company typePrivate
- Founded2008
- HeadquartersBroomall, United States
- Headcount—
- GTM typeB2B
- OfferingHardware or Manufacturing
PeriRx firmographics
Firmographics- Name
- PeriRx
- Website
- https://perirx.com
- Company type
- Private
- Founded year
- 2008
- Operating status
- Closed
- Ownership category
- akta.pro rank
PeriRx industry classification
Industry- Product category
- Oral Diagnostics
- NAICS
- Medical and Diagnostic Laboratories (62151)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Companion Diagnostics (CDx) & Therapy Selection Assays (HLAAALAF)
Keywords
Where PeriRx is headquartered
LocationHeadquarters
- HQ city
- Broomall
- HQ country
- United States
- HQ region
- North America
Markets served
PeriRx business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | — | Domain purchase - one-time payment |
| One time/ perpetual license | Monthly | Domain purchase - payment plan |
PeriRx product offering
Product offeringCore offering
PeriRx develops a breakthrough, non-invasive, oral diagnostic technology. The company's core work centers on creating diagnostic tools that leverage oral sampling to enable detection of health conditions without invasive procedures. The PeriRx.com domain is currently listed for sale on HugeDomains, suggesting the company's current web presence is inactive.
Differentiator
Problem solved
Functional benefit
Companies that use PeriRx
Customer profileIdeal customer profiles1 record
PeriRx technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
PeriRx partnerships and signals
Strategic signalRecent moves2 records
Expansion highlights2 records
PeriRx competitors and assessment
Company assessmentBroad incumbents
- Abbott (Diagnostics): Abbott operates one of the largest diagnostics franchises globally, spanning immunoassays, point-of-care, and infectious disease testing — including rapid test formats. It is comparable as a broad incumbent whose non-invasive and rapid-testing portfolios compete for the same clinical decision-making budget as PeriRx's claimed technology.
- Quest Diagnostics: Quest is one of the largest U.S. clinical laboratory networks, offering a broad menu of diagnostic testing services. It is comparable to PeriRx as a downstream channel and potential commercialization partner for any oral diagnostics assays PeriRx might bring to market.
- Labcorp: Labcorp is a leading global clinical laboratory and diagnostics services provider. It is comparable to PeriRx as both a competing diagnostics service channel and a potential commercialization/acquirer for novel non-invasive oral diagnostic assays.
- Becton, Dickinson and Company (BD): BD manufactures diagnostic systems and consumables across microbiology, molecular, and point-of-care testing. It is comparable as a diversified diagnostics incumbent with non-invasive / rapid testing product lines that overlap with PeriRx's oral diagnostics positioning.
- QuidelOrtho: QuidelOrtho is a large diagnostics incumbent with a portfolio that includes rapid point-of-care immunoassays and infectious disease testing. It is comparable to PeriRx as a broad diagnostics player that has historically targeted non-invasive / rapid testing use cases similar in spirit to PeriRx's claimed niche.
Emerging players
- EKF Diagnostics: EKF Diagnostics develops point-of-care analyzers and rapid test devices for a range of clinical and industrial applications. It is comparable as a focused, non-invasive / rapid diagnostics specialist whose offerings intersect with PeriRx's oral diagnostic positioning.
- Meridian Bioscience: Meridian develops diagnostic test kits and reagents with a focus on infectious disease and gastrointestinal testing. It is comparable to PeriRx as a focused diagnostics developer targeting non-invasive and easy-to-use test formats.
Direct peers
- Salimetrics: Salimetrics specializes in salivary bioscience — saliva-based assays for hormones, stress, and other biomarkers. It is comparable to PeriRx on the 'oral/saliva diagnostics' axis, though it focuses more on research-grade assays than clinical products.
- DNA Genotek (a subsidiary of OraSure Technologies): DNA Genotek develops saliva-based DNA and RNA collection kits used in diagnostics and research. It overlaps with PeriRx on the oral-sample collection and non-invasive diagnostics value proposition.
- OraSure Technologies: OraSure is the leading pure-play developer of oral-fluid (saliva-based) diagnostic collection and testing products for infectious disease, drugs of abuse, and other applications. It is the most direct comparable to PeriRx's positioning as an oral, non-invasive diagnostics developer.
Market position
Strengths2 records
Weaknesses3 records
Competitive moat2 records
Key risks4 records
Key highlights2 records
Customer concentration
PeriRx financial estimates
Financial estimateRevenue estimate
Valuation estimate
PeriRx leadership team
Management profileNumber of profiles
Profiles1 record
PeriRx funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PeriRx M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PeriRx
What does PeriRx do?
PeriRx develops a breakthrough, non-invasive, oral diagnostic technology. The company's core work centers on creating diagnostic tools that leverage oral sampling to enable detection of health conditions without invasive procedures. The PeriRx.com domain is currently listed for sale on HugeDomains, suggesting the company's current web presence is inactive.
Is PeriRx a public or private company?
PeriRx is a private company. It is classified as founder individual operated bootstrapped and is currently closed.
When was PeriRx founded?
PeriRx was founded in 2008.
Where is PeriRx based?
PeriRx is headquartered in Broomall, United States, in the North America region.
Who are PeriRx's main competitors?
Broad incumbents on record are Abbott (Diagnostics), Quest Diagnostics, Labcorp, Becton, Dickinson and Company (BD) and QuidelOrtho. Emerging players are EKF Diagnostics and Meridian Bioscience. Direct peers are Salimetrics, DNA Genotek (a subsidiary of OraSure Technologies) and OraSure Technologies.
Does PeriRx have an API?
No public API is recorded for PeriRx.
What industry is PeriRx in?
PeriRx's product category is Oral Diagnostics. Its primary akta.pro industry code is HLAAALAF, Companion Diagnostics (CDx) & Therapy Selection Assays. Its NAICS code is 62151 and its SIC code is 2835.